Renaissance Technologies
LYEL icon

Renaissance Technologies’s Lyell Immunopharma LYEL Stock Holding History

Renaissance Technologies’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.85M Buy
189,122
+58,932
+45% +$784K ﹤0.01% 1993
2026
Q2 		$1.83M Buy
130,190
+13,779
+12% +$249K ﹤0.01% 2008
2026
Q1 		$2.34M Buy
116,411
+76,921
+195% +$1.8M ﹤0.01% 1818
2025
Q4 		$1.22M Sell
39,490
-24,500
-38% -$548K ﹤0.01% 2174
2025
Q3 		$1.04M Sell
63,990
-3,200
-5% -$36.5K ﹤0.01% 2461
2025
Q2 		$594K Sell
67,190
-21,235
-24% -$194K ﹤0.01% 2753
2025
Q1 		$951K Buy
88,425
+7,818
+10% +$95.8K ﹤0.01% 2457
2024
Q4 		$1.03M Buy
80,607
+70,737
+717% +$1.4M ﹤0.01% 2482
2024
Q3 		$272K Buy
9,870
+2,255
+30% +$66.3K ﹤0.01% 3010
2024
Q2 		$221K Sell
7,615
-13,560
-64% -$646K ﹤0.01% 3011
2024
Q1 		$944K Buy
21,175
+17,550
+484% +$751K ﹤0.01% 2523
2023
Q4 		$141K Buy
+3,625
New +$131K ﹤0.01% 3226
2022
Q4 		– Sell
-2,035
Closed -$298K – 4280
2022
Q3 		$298K Sell
2,035
-475
-19% -$64.3K ﹤0.01% 3216
2022
Q2 		$327K Sell
2,510
-165
-6% -$16.9K ﹤0.01% 3404
2022
Q1 		$270K Buy
+2,675
New +$324K ﹤0.01% 3515

Other funds holding LYEL

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $149M AUM 2.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Decheng Capital
Decheng Capital Menlo Park, California $685M AUM 129.22% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
HSG Holding
HSG Holding Na, Hong Kong $1.26B AUM 34.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Renaissance Technologies's LYEL Position: Q3 2026 in Review

Renaissance Technologies increased its Lyell Immunopharma (LYEL) stake by 45% in Q3 2026, buying an estimated $784K and bringing the position to 189,122 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Renaissance Technologies first reported a position in LYEL in Q1 2022 and has held it in 15 quarters since. The position peaked at $2.34M in Q1 2026. 69 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • Renaissance Technologies held 189,122 shares of Lyell Immunopharma worth $1.85M as of Q3 2026.
  • Renaissance Technologies bought 58,932 Lyell Immunopharma shares in Q3 2026, an estimated $784K.
  • Lyell Immunopharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #1993 holding.
  • Renaissance Technologies first reported a position in Lyell Immunopharma in Q1 2022 and has held it in 15 quarters since.
  • Renaissance Technologies's Lyell Immunopharma position peaked at $2.34M in Q1 2026.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.